The fight against cancer is bolstered by a growing Liposomal Doxorubicin Market, a powerful chemotherapy drug. According to a recent analysis, the market is estimated to reach a value of USD 2.367.5 million by 2034, reflecting a significant increase from USD 1,281.3 million in 2024. This translates to a steady growth rate of 6.3% over …